Patent Foramen Ovale and Stroke–Current Status

Patent foramen ovale (PFO) is growing in clinical interest because of a renewed focus on embolic stroke of undetermined source (ESUS), the PFO attributable fraction (the 10-point Risk of Paradoxical Embolism score), technical advances in PFO diagnosis, and the emergence of endovascular device closure as a treatment option. However, recent randomized controlled trials of the management of patients with ESUS and PFO failed to demonstrate the superiority of closure over medical treatment. The mechanisms of stroke other than paradoxical embolism may be important in patients with ESUS and PFO. This paper reviews the current understanding of the pathophysiology of stroke and therapeutic options in patients with PFO and ESUS.

[1]  Kijeong Lee,et al.  D-dimer for prediction of long-term outcome in cryptogenic stroke patients with patent foramen ovale , 2015, Thrombosis and Haemostasis.

[2]  H. Kamel,et al.  Left Atrial Enlargement and Stroke Recurrence: The Northern Manhattan Stroke Study , 2015, Stroke.

[3]  A. Furlan.  Brief history of patent foramen ovale and stroke. , 2015, Stroke.

[4]  R. Rajan,et al.  Interictal cerebral and systemic endothelial dysfunction in patients with migraine: a case–control study , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  F. Gaita,et al.  Patent foramen ovale treatment strategy: an Italian large prospective study , 2014, Journal of cardiovascular medicine.

[6]  S. Connolly,et al.  Embolic strokes of undetermined source: the case for a new clinical construct , 2014, The Lancet Neurology.

[7]  B. Ovbiagele,et al.  Evaluation of Cryptogenic Stroke With Advanced Diagnostic Techniques , 2014, Stroke.

[8]  M. Stoddard,et al.  Determination of the Optimum Number of Cardiac Cycles to Differentiate Intra‐Pulmonary Shunt and Patent Foramen Ovale by Saline Contrast Two‐ and Three‐Dimensional Echocardiography , 2014, Echocardiography.

[9]  G. Guyatt,et al.  Systematic review of percutaneous closure versus medical therapy in patients with cryptogenic stroke and patent foramen ovale , 2014, BMJ Open.

[10]  D. Calvet,et al.  Closure of patent foramen ovale in cryptogenic stroke: a never ending story. , 2014, Current opinion in neurology.

[11]  V. Chair,et al.  Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. , 2014, Stroke.

[12]  Ji Won Kim,et al.  Association between the Amount of Right-to-Left Shunt and Infarct Patterns in Patients with Cryptogenic Embolic Stroke: A Transcranial Doppler Study , 2013, International journal of stroke : official journal of the International Stroke Society.

[13]  J. J. Piek,et al.  Silent cerebral infarcts associated with cardiac disease and procedures , 2013, Nature Reviews Cardiology.

[14]  Jae-Kwan Song,et al.  Imaging Characteristics of Ischemic Strokes Related to Patent Foramen Ovale , 2013, Stroke.

[15]  Jae-Kwan Song,et al.  Patent foramen ovale and infarct volume in cryptogenic stroke. , 2013, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[16]  D. Kent,et al.  An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke , 2013, Neurology.

[17]  C. DeCarli,et al.  Patent foramen ovale, subclinical cerebrovascular disease, and ischemic stroke in a population-based cohort. , 2013, Journal of the American College of Cardiology.

[18]  M. Alshaher,et al.  Intrapulmonary shunt is a potentially unrecognized cause of ischemic stroke and transient ischemic attack. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[19]  J. Carroll,et al.  Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. , 2013, The New England journal of medicine.

[20]  G. Schuler,et al.  Percutaneous closure of patent foramen ovale in cryptogenic embolism. , 2013, The New England journal of medicine.

[21]  D. Na,et al.  Paradoxical embolism as a cause of silent brain infarctions in healthy subjects: the ICONS study (Identification of the Cause of Silent Cerebral Infarction in Healthy Subjects) , 2013, European journal of neurology.

[22]  A. Furlan,et al.  Letter by Furlan regarding "critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: the hole truth?". , 2013, Stroke.

[23]  A. Wahl,et al.  Critique of closure or medical therapy for cryptogenic stroke with patent foramen ovale: the hole truth? , 2012, Stroke.

[24]  G. Kitsios,et al.  Recurrent stroke on imaging and presumed paradoxical embolism , 2012, Neurology.

[25]  R. Felberg,et al.  Closure or medical therapy for cryptogenic stroke with patent foramen ovale. , 2012, The New England journal of medicine.

[26]  E. Warburton,et al.  Increased Incidence of Interatrial Block in Younger Adults with Cryptogenic Stroke and Patent Foramen Ovale , 2011, Cerebrovascular Diseases Extra.

[27]  V. Sharma,et al.  Safety of transcranial Doppler ‘bubble study’ for identification of right to left shunts: an international multicentre study , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[28]  D. Kent,et al.  Is patent foramen ovale a modifiable risk factor for stroke recurrence? , 2010, Stroke.

[29]  J. Tobis,et al.  The Association of Patent Foramen Ovale Morphology and Stroke Size in Patients With Paradoxical Embolism , 2010, Circulation. Cardiovascular interventions.

[30]  S. Homma,et al.  Patent Foramen Ovale and Stroke , 2005, Circulation.

[31]  L. Roncon,et al.  Left atrial dysfunction in patients with patent foramen ovale and atrial septal aneurysm: an alternative concurrent mechanism for arterial embolism? , 2009, JACC. Cardiovascular interventions.

[32]  D. Kent,et al.  Patent Foramen Ovale in Cryptogenic Stroke: Incidental or Pathogenic? , 2009, Stroke.

[33]  R. Stingele,et al.  Association of right-to-left shunt with frontal white matter lesions in T2-weighted MR imaging of stroke patients , 2009, Neuroradiology.

[34]  H. Lee,et al.  Patent foramen ovale: diagnosis with multidetector CT--comparison with transesophageal echocardiography. , 2009, Radiology.

[35]  A. Boyd,et al.  Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications. , 2008, American heart journal.

[36]  J. Martí-Fàbregas,et al.  Recurrent Stroke and Massive Right-to-Left Shunt: Results From the Prospective Spanish Multicenter (CODICIA) Study , 2008, Stroke.

[37]  C. McCollum,et al.  Paradoxical embolisation and cerebral white matter lesions in dementia. , 2008, The British journal of radiology.

[38]  P. Koudstaal,et al.  Silent brain infarcts: a systematic review , 2007, The Lancet Neurology.

[39]  E. Radue,et al.  Diffusion-Weighted Imaging in Stroke Attributable to Patent Foramen Ovale: Significance of Concomitant Atrial Septum Aneurysm , 2006, Stroke.

[40]  H. Diener,et al.  [Patent foramen ovale, atrial septum aneurysm, and stroke. An examination of the status of recent evidence]. , 2005, Der Nervenarzt.

[41]  H. Oe,et al.  Is stroke a paradoxical embolism in patients with patent foramen ovale? , 2005, Internal medicine.

[42]  H. Diener,et al.  Offenes Foramen ovale, Vorhofseptumaneurysma und Hirninfarkt , 2005, Der Nervenarzt.

[43]  G. Anzola,et al.  Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale , 2003, European journal of neurology.

[44]  R. Sacco,et al.  Effect of Medical Treatment in Stroke Patients With Patent Foramen Ovale: Patent Foramen Ovale in Cryptogenic Stroke Study , 2002, Circulation.

[45]  J. Coste,et al.  Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. , 2001, The New England journal of medicine.

[46]  K. Fukuchi,et al.  Embolic distribution through patent foramen ovale demonstrated by (99m)Tc-MAA brain SPECT after Valsalva radionuclide venography. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[47]  M. Niemelä,et al.  Ear Oximetry: A Noninvasive Method for Detection of Patent Foramen Ovale: A Study Comparing Dye Dilution Method and Oximetry With Contrast Transesophageal Echocardiography , 2001, Stroke.

[48]  E. Zanette,et al.  Detection of Right-to-Left Shunt with Ultrasound Contrast Agent and Transcranial Doppler Sonography , 2000, Cerebrovascular Diseases.

[49]  I. Bone,et al.  Interatrial septal abnormalities and stroke , 2000, Neurology.

[50]  F. Fedele,et al.  Morphological and Functional Characteristics of Patent Foramen Ovale and Their Embolic Implications , 2000, Stroke.

[51]  B K Khandheria,et al.  Echocardiographic assessment of the left atrial appendage. , 1999, Journal of the American College of Cardiology.

[52]  E. Ringelstein,et al.  Contrast transcranial Doppler ultrasound in the detection of right-to-left shunts. Reproducibility, comparison of 2 agents, and distribution of microemboli. , 1999, Stroke.

[53]  R. Sacco,et al.  Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. , 1998, Stroke.

[54]  A. U. Rickel,et al.  Guidelines for Prevention, I , 1998 .

[55]  P. Lechat,et al.  Prevalence of patent foramen ovale in patients with stroke. , 1988, The New England journal of medicine.

[56]  W. Edwards,et al.  Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. , 1984, Mayo Clinic proceedings.